Track market-moving stories before they get noisy

Bloom Energy shares are experiencing downward pressure. Why are BE shares declining? What Is Driving Bloom Energy’s Recent Performance?Bloom Energy last week posted second-quarter EPS of 78 cents versus a 42-cent consensus estimate, while revenue came in at $1.065 billion versus $851.4 million expected – its first quarter above $1 billion in sales.

The company also lifted FY 2026 revenue guidance to a range of $3.9 billion to $4.2 billion, while Brookfield increased its commitment to finance Bloom deployments to $25 billion from $5 billion.

What Management Is SayingBloom Energy leadership emphasized that rapid expansion across AI infrastructure is creating unprecedented structural demand for on-site power solutions.

Founder and CEO KR Sridhar highlighted the shift in market adoption during the call. “The demand for Bloom Energy’s solutions keeps accelerating every quarter as customers who traditionally defaulted to combustion technologies are now proactively choosing Bloom as a superior power solution,” Sridhar said.

“Today, all the major US hyperscalers and over a dozen US neoclouds, AI labs, and colocation data center operators have validated and approved our power solutions for their AI factories. Bloom is now a standard for AI onsite power.”

Sridhar underscored the urgency facing data centers, noting that “chips without power are just inventory” and contextualized the growth milestone: “It took Bloom 21 years to deliver its first billion-dollar year in 2022. It took us another three years to double our 2022 revenue. Now, we are guiding to double that revenue in just one year, having achieved our first $1 billion quarter.”

The Durability DebateBE Shares Edge Lower Wednesday MorningBE Price Action: Bloom Energy shares were down 2.77% at $221.80 during premarket trading on Wednesday, according to Benzinga Pro data.

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Wall Street analysts forecast that Axsome Therapeutics (AXSM - Free Report) will report quarterly loss of -$0.99 per share in its upcoming release, pointing to a year-over-year decline of 7.6%. It is anticipated that revenues will amount to $224.52 million, exhibiting an increase of 49.6% compared to the year-ago quarter.

The consensus EPS estimate for the quarter has undergone a downward revision of 14.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Given this perspective, it's time to examine the average forecasts of specific Axsome metrics that are routinely monitored and predicted by Wall Street analysts.

Based on the collective assessment of analysts, 'Revenues- Product sales, net' should arrive at $222.61 million. The estimate suggests a change of +49.4% year over year.

Analysts forecast 'Product Sales, net- Auvelity' to reach $174.71 million. The estimate indicates a year-over-year change of +46.1%.

Analysts expect 'Product Sales, net- Sunosi' to come in at $33.79 million. The estimate suggests a change of +12.6% year over year.

View all Key Company Metrics for Axsome here>>>

Shares of Axsome have demonstrated returns of -15.1% over the past month compared to the Zacks S&P 500 composite's +3.5% change. With a Zacks Rank #4 (Sell), AXSM is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

CDW (CDW - Free Report) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.8 per share. This compares to earnings of $2.6 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +3.93%. A quarter ago, it was expected that this information technology company would post earnings of $2.28 per share when it actually produced earnings of $2.28, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

CDW, which belongs to the Zacks Computers - IT Services industry, posted revenues of $6.57 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 5.07%. This compares to year-ago revenues of $5.98 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

CDW shares have added about 13.1% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for CDW?While CDW has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for CDW was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.91 on $5.99 billion in revenues for the coming quarter and $10.75 on $23.57 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the bottom 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Serve Robotics Inc. (SERV - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.

This company is expected to post quarterly loss of $0.69 per share in its upcoming report, which represents a year-over-year change of -91.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Serve Robotics Inc.'s revenues are expected to be $3.54 million, up 452.7% from the year-ago quarter.

GlobalFoundries Inc. (GFS - Free Report) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.42 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.55%. A quarter ago, it was expected that this company would post earnings of $0.35 per share when it actually produced earnings of $0.4, delivering a surprise of +14.29%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

GlobalFoundries, which belongs to the Zacks Electronics - Semiconductors industry, posted revenues of $1.79 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.42%. This compares to year-ago revenues of $1.69 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

GlobalFoundries shares have added about 49% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for GlobalFoundries?While GlobalFoundries has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for GlobalFoundries was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.50 on $1.87 billion in revenues for the coming quarter and $1.89 on $7.28 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Electronics - Semiconductors is currently in the top 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Broadcom Inc. (AVGO - Free Report) , is yet to report results for the quarter ended July 2026.

This chipmaker is expected to post quarterly earnings of $3.22 per share in its upcoming report, which represents a year-over-year change of +90.5%. The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level.

Broadcom Inc.'s revenues are expected to be $29.47 billion, up 84.7% from the year-ago quarter.

NCR Voyix (VYX - Free Report) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +13.33%. A quarter ago, it was expected that this maker of ATMs and other hardware and software to handle payments would post earnings of $0.08 per share when it actually produced earnings of $0.1, delivering a surprise of +25%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

NCR Voyix, which belongs to the Zacks Computer - Integrated Systems industry, posted revenues of $523 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.95%. This compares to year-ago revenues of $666 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

NCR Voyix shares have lost about 12.9% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for NCR Voyix?While NCR Voyix has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for NCR Voyix was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.27 on $540 million in revenues for the coming quarter and $0.89 on $2.2 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computer - Integrated Systems is currently in the top 9% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Hewlett Packard Enterprise (HPE - Free Report) , is yet to report results for the quarter ended July 2026.

This information technology products and services provider is expected to post quarterly earnings of $0.93 per share in its upcoming report, which represents a year-over-year change of +111.4%. The consensus EPS estimate for the quarter has been revised 0.2% lower over the last 30 days to the current level.

Hewlett Packard Enterprise's revenues are expected to be $12 billion, up 31.4% from the year-ago quarter.

NiSource (NI - Free Report) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +6.67%. A quarter ago, it was expected that this energy holding company would post earnings of $1.06 per share when it actually produced earnings of $1.06, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

NiSource, which belongs to the Zacks Utility - Electric Power industry, posted revenues of $1.36 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.98%. This compares to year-ago revenues of $1.28 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

NiSource shares have added about 6.6% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for NiSource?While NiSource has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for NiSource was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.21 on $1.35 billion in revenues for the coming quarter and $2.09 on $6.94 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Electric Power is currently in the bottom 29% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Algonquin Power & Utilities (AQN - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 7.

This utility operator is expected to post quarterly earnings of $0.06 per share in its upcoming report, which represents a year-over-year change of +50%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Algonquin Power & Utilities' revenues are expected to be $552.5 million, up 4.7% from the year-ago quarter.

For the quarter ended June 2026, Regal Rexnord (RRX - Free Report) reported revenue of $1.56 billion, up 4.2% over the same period last year. EPS came in at $2.99, compared to $2.48 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.58 billion, representing a surprise of -1.48%. The company delivered an EPS surprise of +15%, with the consensus EPS estimate being $2.60.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Regal Rexnord performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Automation & Motion Control (AMC): $477.7 million versus the three-analyst average estimate of $463.99 million. The reported number represents a year-over-year change of +16.2%.Revenues- Industrial Powertrain Solutions (IPS): $669.4 million versus $676.94 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +3% change.Revenues- Power Efficiency Solutions (PES): $411.3 million versus the three-analyst average estimate of $433.02 million. The reported number represents a year-over-year change of -5.5%.Adjusted EBITDA- Industrial Powertrain Solutions (IPS): $181.4 million compared to the $178.38 million average estimate based on three analysts.Adjusted EBITDA- Automation & Motion Control (AMC): $100.8 million versus the three-analyst average estimate of $88.54 million.Adjusted EBITDA- Power Efficiency Solutions (PES): $84.4 million versus the three-analyst average estimate of $72.8 million.View all Key Company Metrics for Regal Rexnord here>>>

Shares of Regal Rexnord have returned +4% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

, /PRNewswire/ -- The board of directors of The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, today declared a quarterly cash dividend of 36 cents per share. The dividend is payable on Aug. 28, 2026, to shareholders of record as of Aug. 18, 2026.

Timken has paid a dividend on its common shares every quarter since its original listing on the New York Stock Exchange (NYSE) in 1922. The upcoming dividend represents 417 consecutive quarters, one of the longest-running dividend streaks among NYSE-listed companies. In addition, 2026 marks the company's thirteenth consecutive year of annual dividend growth.

About The Timken Company
The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, designs and manufactures highly engineered systems and components for customers in strategic end markets, including aerospace and defense, power and electrification, and automation and industrial solutions. With more than 125 years of specialized expertise and a multinational presence, Timken is a trusted partner worldwide, innovating and powering performance across the application lifecycle. The company posted $4.6 billion in sales in 2025 and employs approximately 19,000 people, operating from 45 countries. Learn more at www.timken.com or @TheTimkenCompany.

Media Relations:
Sarah Factor
234.262.4878
[email protected]

Investor Relations:
Neil Frohnapple
234.262.2310
[email protected] 

SOURCE The Timken Company

, /PRNewswire/ --

Q2 2026 Adjusted EBITDA loss attributable to IEP was $134 million, compared to Adjusted EBITDA attributable to IEP of $40 million in Q2 2025 Q2 2026 net loss attributable to IEP was $355 million, compared to a net loss of $165 million in Q2 2025 Indicative Net Asset Value was approximately $2.6 billion as of June 30, 2026, a decrease of $765 million compared to March 31, 2026. This decrease was primarily due to a decrease of $435 million in the value of our long position in CVI and a decrease of $243 million related to the Holding Company's interest in the Investment Funds primarily driven by net losses from broad market hedges. IEP declares second quarter distribution of $0.50 per depositary unit Statement from Mr. Icahn

IEP Chairman Carl C. Icahn stated: "Over the years, we have maintained a significant hedge position against our refining investments. While I believe this strategy has generally served well in mitigating risk, our results this quarter were impacted by exceptional geopolitical events that disproportionately affected our long refining exposure versus crack spreads and other short refinery positions. Importantly, the strong rebound in our refining investment during July underscores the temporary nature of these dislocations and highlights the timing differences that can occur between our underlying positions and related hedges. In addition, we are continuing to right-size our hedge portfolio to better align with our underlying exposures. We believe these adjustments will help reduce periodic volatility, improve the consistency of our performance, and support more balanced risk-adjusted returns going forward.

Throughout the history of IEP, there have been periods when many of our controlled positions (where we have owned more than 50%) have been undervalued and I believe such a period exists today. Some examples of undervalued controlled positions ultimately becoming profitable for us due to our activism and patience as long-term holders include Pep Boys, the Nashville East Bank Scrapyard, PSC Metals, Ferrous Resources, American Railcar Industries, Tropicana Entertainment, Federal-Mogul, the Fontainebleau Las Vegas, American Railcar Leasing and the Stratosphere Hotel and Casino, each of which was sold for a value in excess of the value at which they were carried on our books. A good current example of one of these is CVR Energy, of which we own 71%. I believe the current market environment is breeding extremely attractive opportunities for refineries such as CVR given the huge capital commitments and exceedingly long time necessary to build new refineries, as well as the threats to existing worldwide refining infrastructure resulting from the current geopolitical situation. I believe that CVR will eventually be on the list of undervalued assets that prove to be extremely profitable for us just as the ones mentioned above and, together with the CVR management team, we are actively focused on opportunities to increase long-term value.

My optimism is also buoyed by our liquidity position and I look forward to updating our unitholders next quarter."

Financial Summary

For the three months ended June 30, 2026, revenues were $3.0 billion and net loss attributable to IEP was $355 million, or a loss of $0.52 per depositary unit. For the three months ended June 30, 2025, revenues were $2.4 billion and net loss attributable to IEP was $165 million, or a loss of $0.30 per depositary unit. Adjusted EBITDA loss attributable to IEP was $134 million for the three months ended June 30, 2026, compared to Adjusted EBITDA attributable to IEP of $40 million for the three months ended June 30, 2025.[1] 

For the six months ended June 30, 2026, revenues were $5.2 billion and net loss attributable to IEP was $814 million, or a loss of $1.22 per depositary unit. For the six months ended June 30, 2025, revenues were $4.2 billion and net loss attributable to IEP was $587 million, or a loss of $1.08 per depositary unit. Adjusted EBITDA loss attributable to IEP was $350 million for the six months ended June 30, 2026, compared to Adjusted EBITDA loss attributable to IEP of $188 million for the six months ended June 30, 2025.1 

As of June 30, 2026, indicative net asset value decreased $765 million compared to March 31, 2026. This decrease was primarily due to a decrease of $435 million in the value of our long position in CVI and a decrease of $243 million related to the Holding Company's interest in the Investment Funds primarily driven by net losses from broad market hedges.

On August 3, 2026, the Board of Directors of the general partner of Icahn Enterprises declared a quarterly distribution in the amount of $0.50 per depositary unit, which will be paid on or about September 23, 2026 to depositary unitholders of record at the close of business on August 17, 2026. Depositary unitholders will have until September 11, 2026 to make a timely election to receive either cash or additional depositary units. If a unitholder does not make a timely election, it will automatically be deemed to have elected to receive the distribution in additional depositary units. Depositary unitholders who elect to receive (or who are deemed to have elected to receive) additional depositary units will receive units valued at the volume weighted average trading price of the units during the five consecutive trading days ending September 18, 2026. Icahn Enterprises will make a cash payment in lieu of issuing fractional depositary units to any unitholders electing to receive (or who are deemed to have elected to receive) depositary units.

1

The presentation of Adjusted EBITDA in this release for Q2 2025 has been prepared using a calculation with different exclusions than what has been used when preparing Adjusted EBITDA for prior periods, including our prior presentation of Adjusted EBIDA for Q2 2025. See "Uses of Non-GAAP Financial Measures" at the end of this press release for additional explanation of the updates in our presentation.

Icahn Enterprises L.P., a master limited partnership, is a diversified holding company owning subsidiaries currently engaged in the following continuing operating businesses: Investment, Energy, Automotive, Food Packaging, Real Estate, Home Fashion and Pharma.

Caution Concerning Forward-Looking Statements

This release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, many of which are beyond our ability to control or predict. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Icahn Enterprises and its subsidiaries. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors, including risks related to economic downturns, substantial competition and rising operating costs; risks related to our investment activities, including the nature of the investments made by the private funds in which we invest and  the impact of the use of leverage through options, short sales, swaps, forwards and other derivative instruments, including the risk of counterparty termination and early settlement of such positions; risks related to our ability to comply with the covenants in our senior notes and the risk of foreclosure on the assets securing our notes; risks related to our ability to refinance our debt; our ability to continue to meet our liquidity needs; declines in the fair value of our investments, losses in the private funds and loss of key employees; risks related to our ability to continue to conduct our activities in a manner so as to not be deemed an investment company under the Investment Company Act of 1940, as amended, or to be taxed as a corporation; risks related to short sellers and associated litigation and regulatory inquiries; risks related to our general partner and controlling unitholder; pledges of our units by our controlling unitholder; risks related to our energy business, including the volatility and availability of crude oil, other feed stocks and refined products, declines in global demand for crude oil, refined products and liquid transportation fuels, unfavorable refining margin (crack spread), interrupted access to pipelines, significant fluctuations in nitrogen fertilizer demand in the agricultural industry and seasonality of results; volatile commodity pricing and higher industry utilization and oversupply risks related to potential strategic transactions involving our Energy segment, and the impact of tariffs; risks related to our automotive activities and exposure to adverse conditions in the automotive industry; risks related to our food packaging activities, including competition from better capitalized competitors, inability of our suppliers to timely deliver raw materials, and the failure to effectively respond to industry changes in casings technology; supply chain issues; inflation, including increased costs of raw materials and shipping; interest rate increases; labor shortages and workforce availability; risks related to our real estate activities, including the extent of any tenant bankruptcies and insolvencies; risks related to our home fashion operations, including changes in the availability and price of raw materials, manufacturing disruptions, and changes in transportation costs and delivery times; the impacts from the Russia/Ukraine conflict and conflict in the Middle East, including the U.S.-Israel and Iran war, and any related economic volatility, disruptions to global commodity markets, export controls and other economic sanctions; political and regulatory uncertainty, including changing economic policy and the imposition of tariffs; and other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission including our Annual Report on Form 10-K and our quarterly reports on Form 10-Q under the caption "Risk Factors." Additionally, there may be other factors not presently known to us or which we currently consider to be immaterial that may cause our actual results to differ materially from the forward-looking statements. Past performance in our Investment segment is not indicative of future performance. We undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise. 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

Three Months Ended
June 30, 

Six Months Ended
June 30, 

2026

2025

2026

2025

(in millions, except per unit amounts)

Revenues:

Net sales

$

3,081

$

2,143

$

5,392

$

4,145

Other revenues from operations

175

172

336

340

Net loss from investment activities

(334)

(74)

(636)

(468)

Interest and dividend income

49

69

96

152

(Loss) gain on disposition of assets, net

(1)

47

(3)

44

Other income (loss), net

5

12

(4)

23

2,975

2,369

5,181

4,236

Expenses:

Cost of goods sold

2,883

2,118

5,223

4,134

Other expenses from operations

147

154

288

305

Selling, general and administrative

203

207

412

408

Dividend expense

5

7

10

15

Impairment

—

2

—

12

Restructuring, net

2

(2)

2

5

Interest expense

121

129

244

257

3,361

2,615

6,179

5,136

Loss before income tax expense

(386)

(246)

(998)

(900)

Income tax (expense) benefit

(2)

45

47

119

Net loss

(388)

(201)

(951)

(781)

Less: net loss attributable to non-controlling interests

(33)

(36)

(137)

(194)

Net loss attributable to Icahn Enterprises

$

(355)

$

(165)

$

(814)

$

(587)

Net loss attributable to Icahn Enterprises allocated to:

Limited partners

$

(348)

$

(162)

$

(798)

$

(576)

General partner

(7)

(3)

(16)

(11)

$

(355)

$

(165)

$

(814)

$

(587)

Basic and Diluted loss per LP unit

$

(0.52)

$

(0.30)

$

(1.22)

$

(1.08)

Basic and Diluted weighted average LP units outstanding

669

545

653

534

Distributions declared per LP unit

$

0.50

$

0.50

$

1.00

$

1.00

CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)

June 30, 

December 31, 

2026

2025

(in millions, except unit amounts)

ASSETS

Cash and cash equivalents

$

1,221

$

1,450

Cash held at consolidated affiliated partnerships and restricted cash

1,971

1,969

Investments

1,498

2,251

Due from brokers

1,131

1,656

Accounts receivable, net

488

393

Related party notes receivable, net

136

129

Inventories, net

978

845

Property, plant and equipment, net

3,616

3,670

Deferred tax asset

187

165

Derivative assets, net

-

7

Goodwill

289

290

Intangible assets, net

330

349

Assets held for sale

22

—

Other assets

1,023

1,041

Total Assets

$

12,890

$

14,215

LIABILITIES AND EQUITY

Accounts payable

$

721

$

690

Accrued expenses and other liabilities

1,524

1,192

Deferred tax liabilities

282

314

Derivative liabilities, net

828

595

Securities sold, not yet purchased, at fair value

1,000

1,382

Debt

6,389

6,616

Total liabilities

10,744

10,789

Equity:

Limited partners: Depositary units: 710,915,093 units issued and outstanding at
June 30, 2026 and 637,209,452 units issued and outstanding at December 31, 2025

1,813

2,728

General partner

(804)

(786)

Equity attributable to Icahn Enterprises

1,009

1,942

Equity attributable to non-controlling interests

1,137

1,484

Total equity

2,146

3,426

Total Liabilities and Equity

$

12,890

$

14,215

Use of Non-GAAP Financial Measures

The Company uses certain non-GAAP financial measures in evaluating its performance. These include non-GAAP EBITDA and Adjusted EBITDA. EBITDA represents earnings from continuing operations before net interest expense (excluding our Investment Segment), income tax (benefit) expense and depreciation and amortization. We define Adjusted EBITDA as EBITDA excluding certain effects of impairment, restructuring costs, transformation costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt, the performance of closed stores and including closing costs, Energy segment unrealized gains/losses on hedging contracts, unrealized gains/losses on Renewable Fuel Standard ("RFS") positions, Energy segment inventory revaluation, and certain other non-operational or non-recurring charges. The Energy segment's basis for determining inventory value impacts are under a GAAP First-In, First-Out ("FIFO") basis. Changes in crude oil prices can cause fluctuations in the inventory valuation of crude oil, work in process and finished goods, thereby resulting in a favorable inventory valuation impact when crude oil prices increase and an unfavorable inventory valuation impact when crude oil prices decrease. The inventory valuation impact is calculated based upon inventory values at the beginning of the accounting period and at the end of the accounting period. We present EBITDA and Adjusted EBITDA on a consolidated basis and on a basis attributable to Icahn Enterprises net of the effects of non-controlling interests. We conduct substantially all of our operations through subsidiaries. The operating results of our subsidiaries may not be sufficient to make distributions to us. In addition, our subsidiaries are not obligated to make funds available to us for payment of our indebtedness, payment of distributions on our depositary units or otherwise, and distributions and intercompany transfers from our subsidiaries to us may be restricted by applicable law or covenants contained in debt agreements and other agreements to which these subsidiaries currently may be subject or into which they may enter into in the future. The terms of any borrowings of our subsidiaries or other entities in which we own equity may restrict dividends, distributions or loans to us. 

We believe that providing EBITDA and Adjusted EBITDA to investors has economic substance as these measures provide important supplemental information of our performance to investors and permits investors and management to evaluate the core operating performance of our business without regard to interest (except with respect to our Investment segment), taxes and depreciation and amortization and certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. Additionally, we believe this information is frequently used by securities analysts, investors and other interested parties in the evaluation of companies that have issued debt. Management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results, as well as in planning, forecasting and analyzing future periods. Adjusting earnings for these charges allows investors to evaluate our performance from period to period, as well as our peers, without the effects of certain items that may vary depending on accounting methods and the book value of assets. Additionally, EBITDA and Adjusted EBITDA present meaningful measures of performance exclusive of our capital structure and the method by which assets were acquired and financed. Effective March 31, 2026, we modified our calculation of Adjusted EBITDA to exclude the impacts of certain of our Energy segment results, including unrealized gains/losses on hedging contracts, unrealized gains/losses on RFS positions, and inventory revaluation. We believe that this revised presentation improves the supplemental information provided to our investors because management believes these are not attributable to or indicative of our underlying operational results of the period or that may obscure results and trends we deem useful and the significance of these measures have been disproportionately impacted by increased volatility in recent periods.

EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under generally accepted accounting principles in the United States, or U.S. GAAP. For example, EBITDA and Adjusted EBITDA: 

do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments;  do not reflect changes in, or cash requirements for, our working capital needs; and  do not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on our debt.  Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. Other companies in the industries in which we operate may calculate EBITDA and Adjusted EBITDA differently than we do, limiting their usefulness as comparative measures. In addition, EBITDA and Adjusted EBITDA do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations. 

EBITDA and Adjusted EBITDA are not measurements of our financial performance under U.S. GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with U.S. GAAP or as alternatives to cash flow from operating activities as a measure of our liquidity. Given these limitations, we rely primarily on our U.S. GAAP results and use EBITDA and Adjusted EBITDA only as a supplemental measure of our financial performance.  

Use of Indicative Net Asset Value Data

The Company uses indicative net asset value as an additional method for considering the value of the Company's assets, and we believe that this information can be helpful to investors. Please note, however, that the indicative net asset value does not represent the market price at which the depositary units trade. Accordingly, data regarding indicative net asset value is of limited use and should not be considered in isolation.

The Company's depositary units are not redeemable, which means that investors have no right or ability to obtain from the Company the indicative net asset value of units that they own. Units may be bought and sold on The Nasdaq Global Select Market at prevailing market prices. Those prices may be higher or lower than the indicative net asset value of the depositary units as calculated by management. 

See below for more information on how we calculate the Company's indicative net asset value. 

June 30, 

March 31,

December 31,

2026

2026

2025

(in millions)(unaudited)

Market-valued Subsidiaries and Investments:

   Holding Company interest in Investment Funds(1)

$ 1,978

$ 2,221

$ 2,711

   CVR Energy(2)

1,961

2,396

1,791

   CVR Partners LP(2)

30

34

28

Total market-valued subsidiaries and investments

$ 3,969

$ 4,651

$ 4,530

Other Subsidiaries:

   Viskase(3)

$ 96

$ 98

$ 53

   Real Estate Segment(4)

1,417

1,394

1,367

   WestPoint Home(1)

148

151

155

   Vivus(1)

153

161

169

   Icahn Automotive Group(5)

765

704

619

Operating Business Indicative Gross Asset Value

$ 6,548

$ 7,159

$ 6,893

   Add: Other Net Assets(6)

99

9

98

Indicative Gross Asset Value

$ 6,647

$ 7,168

$ 6,991

   Add: Holding Company cash and cash equivalents(7)

381

624

839

   Less: Holding Company debt(7)

(4,426)

(4,425)

(4,664)

Indicative Net Asset Value

$ 2,602

$ 3,367

$ 3,166

Indicative net asset value does not purport to reflect a valuation of IEP. The calculated indicative net asset value does not include any value for our Investment Segment other than the fair market value of our investment in the Investment Funds. A valuation is a subjective exercise and indicative net asset value does not necessarily consider all elements or consider in the adequate proportion the elements that could affect the valuation of IEP. Investors may reasonably differ on what such elements are and their impact on IEP. No representation or assurance, express or implied, is made as to the accuracy and correctness of indicative net asset value as of these dates or with respect to any future indicative or prospective results which may vary.  

(1)

Represents GAAP equity attributable to IEP as of each respective date.

(2)

Based on closing share price on each date (or if such date was not a trading day, the immediately preceding trading day) and the number of shares owned by us as of each respective date.

(3)

Management performed a valuation of Viskase with the assistance of third-party consultants to estimate fair-market value. This analysis utilized the average results of a discounted cashflow methodology and a guideline public company methodology. Different judgments or assumptions would result in different estimates of value. Viskase indicative net asset value is derived by allocating our portion of ownership to the total equity value.

(4)

For each period presented, management performed a valuation with the assistance of third-party consultants to estimate fair-market value, which utilized the average results of discounted cashflow and sales comparison methodologies. Different judgments or assumptions would result in different estimates of value. For certain properties under a purchase and sale agreement, indicative fair market value is based on the anticipated sales price adjusted for customary closing costs. In August 2025, certain properties were sold and the value of the consideration received and held in our Real Estate Segment consisted of preferred equity investment and debt and was used in the calculation of indicative fair value.

(5)

For each period presented, management performed a valuation of Icahn Automotive Group ("IAG"), including the Automotive Services business and Automotive Owned Real Estate, with the assistance of third party consultants to estimate fair value. This analysis utilized the average results of a discounted cashflow methodology and a guideline public company methodology. Different judgments or assumptions would result in different estimates of value. During the fourth quarter of 2025 the majority of the Automotive Owned Real Estate was transferred to the Real Estate Segment and as of December 31, 2025 are now presented in the Real Estate Segment line item. In July 2026, IAG entered into a stock purchase agreement to sell Pep Boys – Manny Moe & Jack Holding Corp. for $700 million subject to customary closing conditions and the transaction is expected to close in the coming months. IAG will retain certain businesses, assets and liabilities in connection with this sale. As of June 30, 2026, the value of IAG includes an estimated increase of $97 million in connection with this sale agreement.

(6)

Represents GAAP equity of the Holding Company segment, excluding cash and cash equivalents, debt and non-cash deferred tax assets or liabilities. As of December 31, 2025, March 31, 2026 and June 30, 2026, Other Net Assets includes $6, $5 million and $5 million respectively, of liabilities assumed from the Auto Plus bankruptcy.

(7)

Holding Company's balance as of each respective date.

Three Months Ended June 30, 

Six Months Ended June 30, 

2026

2025

2026

2025

(in millions)(unaudited)

Adjusted EBITDA

Net loss

($388)

($201)

($951)

($781)

Interest expense, net

101

102

207

196

Income tax expense (benefit)

2

(45)

(47)

(119)

Depreciation and amortization

124

132

247

250

EBITDA before non-controlling interests

(161)

(12)

(544)

(454)

Impairment

-

2

-

12

Restructuring costs

1

(1)

1

6

Revaluation of RFS Liability

73

89

124

200

Unrealized loss (gain) on Energy segment derivatives

(7)

2

151

(1)

Inventory valuation impacts, (favorable) unfavorable

(18)

32

(138)

8

(Gain) on disposition of assets

(1)

(46)

-

(44)

Transformation costs

11

12

21

20

(Gain) loss on extinguishment of debt, net

-

(3)

32

(3)

Out of period adjustments

(4)

-

(4)

-

Same store adjustment including closing costs

3

7

8

11

Other

2

-

5

3

Adjusted EBITDA before non-controlling interests

($101)

$82

($344)

($242)

Adjusted EBITDA attributable to IEP

Net loss

($355)

($165)

($814)

($587)

Interest expense, net

90

88

185

171

Income tax expense (benefit)

2

(30)

(37)

(86)

Depreciation and amortization

83

90

166

169

EBITDA attributable to IEP

(180)

(17)

(500)

(333)

Impairment

-

2

-

11

Restructuring costs

1

(1)

1

5

Revaluation of RFS Liability

52

62

88

136

Unrealized loss (gain) on Energy segment derivatives

(5)

1

106

(1)

Inventory valuation impacts, (favorable) unfavorable

(13)

22

(97)

6

(Gain) on disposition of assets

(1)

(46)

-

(44)

Transformation costs

11

12

21

20

(Gain) loss on extinguishment of debt, net

-

(3)

22

(3)

Out of period adjustments

(4)

-

(4)

-

Same store adjustment including closing costs

3

7

8

11

Other

2

1

5

4

Adjusted EBITDA attributable to IEP

($134)

$40

($350)

($188)

Investor Contact:
Robert Flint, Chief Financial Officer
[email protected] 
(800) 255-2737

SOURCE Icahn Enterprises L.P.

Key Takeaways CRGY raised 2026 production guidance after Q2 output hit 335,000 boe/d and free cash flow reached $418M.CRGY lifted Permian synergies to $250-$300M, with most savings expected by late 2026 or early 2027.CRGY sees more than $1B in 2026 levered free cash flow, with rapid deleveraging still the near-term priority. Crescent Energy Company (CRGY - Free Report) centered its second-quarter 2026 earnings call on higher production, lower costs and sharply expanded Permian synergies without a higher development budget. Management also tied stronger free cash flow to faster deleveraging.

Attention now shifts to how quickly the savings reach results, how production trends through the second half and whether Crescent Energy-led development changes improve the 2027 setup.

CRGY Raises the 2026 Operating BarIn the second quarter of 2026, CRGY’s adjusted EPS of $0.69 topped the Zacks Consensus Estimate of $0.59. Revenues of $1.39 billion also beat the $1.23 billion consensus, providing supporting financial context.

Second-quarter execution produced 335,000 barrels of oil equivalent per day, including 140,000 barrels of oil per day, while levered free cash flow reached a record $418 million.

CFO Brandi Kendall raised 2026 total production guidance to 327,000-335,000 barrels of oil equivalent per day, also lifted oil guidance and lowered adjusted operating expense guidance to $11-$12 per barrel. Development capital remained $1.325-$1.425 billion.

Crescent Energy Triples Permian Synergy TargetCEO David Rockecharlie said Crescent Energy has captured about $190 million of annualized Permian synergies and raised the target to $250-$300 million, roughly three times the original $90-$100 million range.

The CEO attributed the increase to operating, infrastructure and commercial improvements. Permian well costs are about 20%-25% below the prior operator’s levels, while field planning, workovers and marketing terms continue to improve.

Kendall said during Q&A that Crescent Energy expects to capture most of the new target as 2026 ends and 2027 begins. She also identified additional 2027 cash flow benefits as the savings are realized.

CRGY Extends the Cost PlaybookRockecharlie said Eagle Ford well costs improved about 5% year over year and now stand more than 25% below 2023 levels. In the Uinta, development costs fell nearly 20% to below $800 per foot.

Chief operating officer Jerome Hall detailed the work behind those gains, including longer laterals, more wells per pad, better workover planning, smaller electric submersible pumps and tighter vendor consolidation.

Hall also highlighted lower chemical use, compression optimization and route planning. His comments framed the savings as repeatable field-level actions rather than a single cost-cutting program.

Crescent Energy Keeps Deleveraging FirstKendall said Crescent Energy expects more than $1 billion of levered free cash flow in 2026 at current commodity prices, providing flexibility for debt reduction, acquisitions and share repurchases.

Crescent Energy redeemed the remaining $259 million of its 2029 senior notes at par after the quarter. It ended June with about $2.2 billion of liquidity and declared a 12-cent quarterly dividend.

When a Stephens analyst asked about capital priorities, Kendall said the near-term focus remains rapid deleveraging. She emphasized that debt repayment, repurchases and drilling must compete for each incremental dollar.

CRGY Q&A Sets the Back-Half CadenceA JPMorgan analyst asked about second-half production. Kendall said oil volumes should move into the mid-130,000-barrel-per-day range in the third quarter as completion timing and a shift toward three-mile Permian laterals affect the cadence.

A Pickering Energy Partners analyst asked whether capital spending would land near the upper end of guidance. Kendall instead directed expectations toward the midpoint, with third- and fourth-quarter spending expected to be relatively even.

A Wolfe Research analyst pressed management on the base decline rate. Hall maintained the target of reducing it from 29% to 25% in 2027 through artificial-lift optimization, compression improvements and technology across more than 8,000 wells.

Crescent Energy Stays Focused on Internal ReturnsRockecharlie’s closing emphasis remained on returns, free cash flow and improving acquired assets. He also pointed to resource expansion across the Permian, Eagle Ford and Uinta as a longer-term inventory opportunity.

Kendall kept the priorities unchanged: protect the dividend, strengthen the balance sheet and direct excess cash toward the highest-return alternatives. The tone was confident on execution while disciplined on spending.

What the Zacks Signals Say About CRGYCRGY currently carries a Zacks Rank #3 (Hold), indicating a neutral near-term estimate-revision signal. Its A scores for Value and Growth, B for Momentum and A VGM Score reflect favorable characteristics across the three styles.

The Style Scores complement the Zacks Rank, with the strongest historical combinations centered on Zacks Rank #1 (Strong Buy) and #2 (Buy) stocks carrying A or B scores. CRGY’s Zacks Rank can change as analysts revise estimates after the reported results.

You can see the complete list of today’s Zacks #1 Rank stocks here.

Cencora (COR - Free Report) came out with quarterly earnings of $4.48 per share, beating the Zacks Consensus Estimate of $4.37 per share. This compares to earnings of $4 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +2.52%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $4.8 per share when it actually produced earnings of $4.75, delivering a surprise of -1.04%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Cencora, which belongs to the Zacks Medical Services industry, posted revenues of $84.75 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 0.16%. This compares to year-ago revenues of $80.66 billion. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Cencora shares have lost about 9.3% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for Cencora?While Cencora has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Cencora was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $4.54 on $88.7 billion in revenues for the coming quarter and $17.79 on $337.93 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Sotera Health Company (SHC - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.

This company is expected to post quarterly earnings of $0.24 per share in its upcoming report, which represents a year-over-year change of +20%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Sotera Health Company's revenues are expected to be $311.13 million, up 5.7% from the year-ago quarter.

Supporting America’s vital Intelligence Community partners, SAIC Intel Space market contract awards surpass $1.6 billion in the first half of FY27 August 05, 2026 08:30 ET  | Source: SAIC, Inc.

RESTON, Va., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Multi-domain intelligence integration leader, Science Applications International Corporation (NASDAQ: SAIC) announced today it has been awarded a $400 million recompete contract supporting a U.S. Intelligence Agency. This increases SAIC’s Intel Space awards to more than $1.6 billion during the first half of fiscal 2027, continuing the sustained momentum in this important market.

Under this contract, SAIC provides advanced systems engineering, technical integration, and mission support services for ground-based Intelligence Community programs that ultimately deliver decisive national advantage. With trusted experience and proven ability to support programs across the Intelligence Community, SAIC was awarded this contract for its expertise in domain systems and delivering intelligence at the speed the mission requires.

“Our intelligence agencies conduct vital work every day that protect the American people,” said Vinnie DiFronzo, Executive Vice President of SAIC’s Air Force, Space and Intelligence Business Group. “We’re proud that this award reflects the sustained confidence our Intel Space partners place in SAIC to rapidly deliver integrated ground solutions in an increasingly complex threat environment. Building on our broader Q1 FY27 performance, this recompete win reinforces the strength of our Intel Space portfolio and the depth of expertise our teams bring to these critical programs.”

Due to the sensitive nature of the work, additional details regarding the customer and specific program activities are not being disclosed.

About SAIC 
SAIC® is a premier mission integrator focused on advancing the power of technology and innovation to serve and protect our world. Our robust portfolio of offerings across the defense, space, intelligence, and civilian markets includes secure high-end solutions in mission IT, enterprise IT, engineering services, and professional services. We integrate emerging technology, rapidly and securely, into mission critical operations that modernize and enable critical national imperatives.

We are approximately 23,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has annual revenues of approximately $7.3 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.

Media Contact: 
Darryn James
[email protected]

Forward-Looking Statements 
Forward-Looking Statements Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at saic.com or on the SEC’s website at sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others. 

Iron Mountain (IRM - Free Report) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $0.48 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +2.86%. A quarter ago, it was expected that this real estate investment trust would post earnings of $1.39 per share when it actually produced earnings of $0.6, delivering a surprise of -56.83%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Iron Mountain, which belongs to the Zacks Business - Information Services industry, posted revenues of $2.03 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.20%. This compares to year-ago revenues of $1.71 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Iron Mountain shares have added about 51.3% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for Iron Mountain?While Iron Mountain has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Iron Mountain was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.47 on $1.98 billion in revenues for the coming quarter and $5.85 on $7.92 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Business - Information Services is currently in the top 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the broader Zacks Business Services sector, Pixelworks (PXLW - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 11.

This maker of chips used in high-end digital video devices is expected to post quarterly loss of $0.20 per share in its upcoming report, which represents a year-over-year change of +80%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Pixelworks' revenues are expected to be $0.3 million, down 96.4% from the year-ago quarter.

Kennametal (KMT - Free Report) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +28.14%. A quarter ago, it was expected that this engineered products maker would post earnings of $0.68 per share when it actually produced earnings of $0.77, delivering a surprise of +13.24%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Kennametal, which belongs to the Zacks Manufacturing - Tools & Related Products industry, posted revenues of $736.61 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.32%. This compares to year-ago revenues of $516.45 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Kennametal shares have added about 26.9% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for Kennametal?While Kennametal has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Kennametal was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.26 on $667.33 million in revenues for the coming quarter and $2.74 on $2.6 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Manufacturing - Tools & Related Products is currently in the bottom 22% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Intellicheck Mobilisa, Inc. (IDN - Free Report) , another stock in the broader Zacks Industrial Products sector, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 13.

This company is expected to post quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of +400%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Intellicheck Mobilisa, Inc.'s revenues are expected to be $5.76 million, up 12.5% from the year-ago quarter.

Edgewell Personal Care (EPC - Free Report) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.92 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +12.50%. A quarter ago, it was expected that this consumer products maker would post earnings of $0.43 per share when it actually produced earnings of $0.6, delivering a surprise of +39.53%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Edgewell Personal, which belongs to the Zacks Consumer Products - Staples industry, posted revenues of $570.1 million for the quarter ended June 2026, missing the Zacks Consensus Estimate by 1.87%. This compares to year-ago revenues of $627.2 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Edgewell Personal shares have added about 67.3% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for Edgewell Personal?While Edgewell Personal has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Edgewell Personal was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.86 on $477.88 million in revenues for the coming quarter and $1.94 on $2 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consumer Products - Staples is currently in the bottom 18% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Grocery Outlet Holding Corp. (GO - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 12.

This supermarket company selling discount, overstocked and closeout products is expected to post quarterly earnings of $0.12 per share in its upcoming report, which represents a year-over-year change of -47.8%. The consensus EPS estimate for the quarter has been revised 5.6% lower over the last 30 days to the current level.

Grocery Outlet Holding Corp.'s revenues are expected to be $1.17 billion, down 1.1% from the year-ago quarter.

5.8.2026 15:53, BAACSG

Průmyslově-technologická skupina CSG oznámila kapitálový vstup do kanadské obranně-technologické společnosti North Vector Dynamics, která vyvíjí pokročilé technologie protivzdušné obrany, přesně naváděné raketové systémy, řešení pro obranu proti bezpilotním prostředkům a hypersonické technologie nové generace. Hodnotu investice se strany rozhodly nezveřejnit, hodnota North Vector Dynamics podle CSG nyní přesahuje 90 mil. USD.

Akvizice zapadá do dlouhodobé strategie skupiny. CSG v posledních letech systematicky rozvíjí své kompetence v oblastech radarových technologií, protivzdušné obrany, řízení letového provozu, autonomních systémů, pohonných systémů pro rakety a bezpilotní prostředky i dalších pokročilých obranných technologií. Řešení vyvíjená společností North Vector Dynamics na tuto strategii podle společnosti přirozeně navazují a rozšiřují technologické portfolio skupiny o další vysoce perspektivní segment.

„Charakter moderních konfliktů se rychle mění. Stále větší význam získávají autonomní systémy, umělá inteligence, pokročilé senzory, přesné navádění a ekonomicky efektivní protivzdušná obrana. North Vector Dynamics vyvíjí rodinu interceptorů, které mají potenciál zásadně ovlivnit podobu těchto schopností v příštích letech. Proto jsme se rozhodli stát nejen investorem, ale především dlouhodobým strategickým partnerem společnosti. Vedle kapitálu jí chceme nabídnout také naše průmyslové zkušenosti, výrobní kapacity a obchodní síť na Ukrajině, v členských státech NATO i dalších partnerských zemích po celém světě,“ říká Michal Strnad, předseda představenstva a generální ředitel CSG.

Akcie CSG Akcie Czechoslovak Group (BAACSG) na Free Marketu pražské burzy posilují o 2,27 % na 451 Kč, na RM-SYSTÉMu akcie rostou o 2,27 % na 450 Kč.

Zdroj: CSG

Michal Bárta
Fio banka, a.s.
Prohlášení

Posted by Defense World Staff on Aug 5th, 2026

Cetera Investment Advisers grew its stake in shares of Rubrik, Inc. (NYSE:RBRK – Free Report) by 36.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 87,025 shares of the company’s stock after buying an additional 23,320 shares during the quarter. Cetera Investment Advisers’ holdings in Rubrik were worth $4,262,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of RBRK. Atlantic Union Bankshares Corp increased its stake in Rubrik by 100.0% in the 4th quarter. Atlantic Union Bankshares Corp now owns 400 shares of the company’s stock worth $31,000 after purchasing an additional 200 shares during the period. Banque Cantonale Vaudoise bought a new position in shares of Rubrik in the third quarter worth approximately $34,000. Triumph Capital Management bought a new position in shares of Rubrik in the fourth quarter worth approximately $33,000. Los Angeles Capital Management LLC purchased a new position in shares of Rubrik in the fourth quarter worth $35,000. Finally, Advocate Investing Services LLC bought a new stake in Rubrik during the 4th quarter valued at $38,000. Institutional investors own 49.54% of the company’s stock.

Wall Street Analysts Forecast Growth RBRK has been the topic of a number of analyst reports. Barclays boosted their price objective on shares of Rubrik from $70.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, June 5th. Rosenblatt Securities reaffirmed a “buy” rating and set a $90.00 price target on shares of Rubrik in a research report on Monday, June 1st. DA Davidson reiterated a “buy” rating and issued a $90.00 price objective (up from $70.00) on shares of Rubrik in a report on Thursday, June 11th. Wedbush reissued an “outperform” rating and set a $90.00 target price on shares of Rubrik in a research note on Thursday, June 11th. Finally, Stephens restated an “overweight” rating and set a $90.00 target price on shares of Rubrik in a report on Monday, June 15th. Twenty-nine research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $94.20.

Get Our Latest Report on RBRK

Rubrik Stock Up 8.5% RBRK opened at $81.11 on Wednesday. The stock has a market cap of $16.69 billion, a PE ratio of -55.94 and a beta of 1.17. The business has a 50 day moving average of $76.35 and a 200-day moving average of $62.86. Rubrik, Inc. has a 52 week low of $42.25 and a 52 week high of $99.75.

Rubrik (NYSE:RBRK – Get Free Report) last issued its quarterly earnings results on Thursday, June 4th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.19. The firm had revenue of $387.07 million during the quarter, compared to analysts’ expectations of $366.31 million. During the same period in the previous year, the company earned ($0.15) earnings per share. Rubrik’s revenue for the quarter was up 39.0% on a year-over-year basis. Rubrik has set its FY 2027 guidance at 0.250-0.350 EPS and its Q2 2027 guidance at 0.030-0.050 EPS. Equities analysts anticipate that Rubrik, Inc. will post -1.16 EPS for the current year.

Insider Buying and Selling In other news, Director Ravi Mhatre sold 3,979 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $71.49, for a total transaction of $284,458.71. Following the completion of the transaction, the director directly owned 113,477 shares in the company, valued at $8,112,470.73. This trade represents a 3.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Yvonne Wassenaar sold 2,838 shares of Rubrik stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $75.00, for a total value of $212,850.00. Following the completion of the transaction, the director directly owned 2,326 shares of the company’s stock, valued at approximately $174,450. This represents a 54.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 292,042 shares of company stock worth $24,379,821 over the last three months. 13.66% of the stock is owned by corporate insiders.

Rubrik Company Profile (Free Report)

Rubrik, Inc is a cloud data management and security company that delivers a unified platform for data protection, disaster recovery, compliance and intelligent data governance. Its flagship offering, the Rubrik Security Cloud, enables organizations to automate backup and recovery workflows across on-premises, edge and multi-cloud environments. By combining policy-driven orchestration with real-time threat detection, Rubrik helps clients guard against ransomware, ensure business continuity and enforce data retention requirements.

The company’s platform supports a range of services including backup and restore, long-term data archiving, replication, and disaster recovery as a service (DRaaS).

Further Reading Five stocks we like better than Rubrik System Upgrade: First Internet Bancorp Options Surge AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push The AI Chip Blockade Is Creating a Shadow Market Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter

Receive News & Ratings for Rubrik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rubrik and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEFirst Trust Advisors LP Has $4.22 Million Stock Holdings in lululemon athletica inc. $LULU

NEXT HEADLINE »Adlai Nortye (ANL) to Announce Quarterly Earnings on Thursday

Shares of the quantum computing company D-Wave Quantum (QBTS +9.26%) plunged last month as investors grew increasingly skeptical that big bets in the tech sector would pay off, including artificial intelligence and quantum computing.

Shares of D-Wave fell 24.6% in July, according to data provided by S&P Global Market Intelligence. And if the recent sell-off is any indication, D-Wave's shares could remain volatile for a while.

Image source: Getty Images.

Investors are concerned about spending Tech investors have been increasingly worried that all of the spending that's happening in the sector won't be worth the cost.

One of the best examples of this came last month, when Alphabet reported its second-quarter results, saying that capital expenditures would rise to $205 billion this year and would likely be higher next year. The spending sent Alphabet's free cash flow into negative territory for the first time in more than two decades.

Alphabet's stock fell after the company released its quarterly results, as investors lost faith that the company's bets in AI are worth the cost. And while D-Wave isn't an AI company, its shares suffered the same fate in July because investors took a similar view that D-Wave's bets on quantum computing won't pay off.

D-Wave reported a net loss of $18.4 million in the first quarter and had just $2.9 million in revenue. And its costs are rising, too, with research and development spending more than doubling to nearly $26 million, and its General and Administrative costs surging 150% to over $20 million.

Investors are looking around and seeing costs rise for tech companies, and they're beginning to question whether holding shares is worth the risk.

D-Wave isn't escaping this sentiment, especially considering that the stock is very expensive, with a price-to-sales (P/S) ratio of 496, compared to the tech sector average P/S ratio of about 6.

Today's Change

(

9.26

%) $

1.85

Current Price

$

21.83

More insight coming, but volatility could be ahead D-Wave will report its second-quarter results on Aug. 6, and analysts' consensus estimates are expecting sales of about $43 million, a 75% increase from the year-ago quarter.

But investors will likely be more focused on D-Wave's spending, and with the company still unprofitable and its shares trading for such a high premium, it's not wrong for them to be skeptical.

It's difficult to say how long investors might remain skeptical of unprofitable tech companies. But it appears that a real shift is underway away shareholders in what they expect from companies.

All of which means that D-Wave's shares could remain volatile in the near term as shareholders question whether waiting around for quantum computing profits is worth the risk.

The XRP Ledger just got a passport. XRPL and its EVM Sidechain are now live on Axelar’s interoperability network, letting users move XRP and other supported assets across more than 80 blockchains without juggling multiple bridges.

The integration, announced on July 20, represents the culmination of a partnership that’s been building since at least 2024, when Axelar was first tapped as the bridge provider for the XRPL EVM Sidechain. That sidechain itself only went live on June 30, 2025. So in roughly three weeks, the team moved from “EVM compatibility exists” to “here’s connectivity to basically every major chain.”

How the plumbing works Axelar operates as a decentralized network that connects disparate blockchains. Its Interchain Token Service handles the actual mechanics of wrapping and unwrapping tokens as they move between chains. You send XRP from the XRP Ledger, and it shows up as a usable asset on Ethereum, Avalanche, Polygon, or whichever of the 80-plus supported chains you’re targeting.

Axelar serves as the exclusive bridge for wrapped XRP moving to and from the XRPL EVM Sidechain.

Advertisement

The cross-chain transfer experience is powered in part by Squid, which provides the user interface layer for moving assets. Squid abstracts away the complexity of selecting routes, estimating fees, and confirming transactions across chains.

The collaboration roster includes Ripple, Peersyst, which developed the XRPL EVM Sidechain, and the Axelar Foundation.

Why EVM compatibility changes the game for XRP The XRP Ledger has historically been somewhat isolated from the broader DeFi ecosystem. Most DeFi protocols run on EVM-compatible chains. The XRP Ledger doesn’t natively speak that language.

The EVM Sidechain solves this by giving XRPL an Ethereum-compatible environment that runs alongside the main ledger. Ripple CTO David Schwartz has emphasized the importance of EVM compatibility for expanding XRP’s reach into institutional use cases.

Axelar co-founder Georgios Vlachos has pointed to institutional applications as a key driver behind the integration. Ripple has long positioned itself as the crypto company that targets enterprise clients, and connecting XRPL to 80-plus chains through a single verified bridge fits that narrative.

What this means for investors The most immediate implication is increased utility for XRP. An asset that can seamlessly move across 80-plus chains has more potential use cases than one confined to a single ledger.

Cross-chain bridges have historically been double-edged swords. The Ronin bridge exploit alone cost over $600M. Axelar’s position as the sole bridge for wrapped XRP concentrates risk in a single point of infrastructure.

Investors should monitor adoption metrics in the coming months: how much wrapped XRP flows through Axelar, which destination chains attract the most volume, and whether DeFi protocols begin building XRP-specific products.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Ucore announces:

the successful completion of its RapidSX™ equipment ("RSX-1") scale-up verification program for its developing Louisiana Strategic Metals Complex in Alexandria, Louisiana

selection of Enhanced Machine A's specific equipment and operational configurations

Halifax, Nova Scotia--(Newsfile Corp. - August 5, 2026) - Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) ("Ucore" or the "Company") is pleased to announce that it has successfully completed the scale-up testing and optimization program for its commercial-scale RapidSX™ computerized and motionless mixing contactor assemblies to be deployed at its Alexandria, Louisiana, Strategic Metals Complex ("SMC"). This contactor equipment scale-up program ("RSX-1") builds on the 7,400+ hours of simulated commercial runtime on the Company's Demonstration Plant ("Demo Plant") at its RapidSX™ Commercialization and Demonstration Facility ("CDF") in Kingston, Ontario.

Figure 1: 4x12" (L) & 1x24" (R) RapidSX™ Contactor Scale-Up Testing & Optimization at the Kingston, Ontario, Commercialization and Demonstration Facility

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/1119/308111_4bc761d6a423a8c1_002full.jpg

The contactor scale-up and optimization program is partially funded by Ucore's US Department of War US$18.4 million Other Transaction Agreement ("OTA") Modification (US$20.4 million total) to facilitate the technology transfer from demonstration-scale in Kingston to full commercial-scale deployment in Louisiana. The completion of this optimized RapidSX™ equipment testing marks a significant milestone in Ucore's pathway to build its first commercial RapidSX™ rare earth separation machine, 'Enhanced Machine A', capable of processing 600 tonnes per year ("tpa") of total rare earth oxides ("TREO").

The Objectives of the RSX-1 scale-up and optimization program were to:

verify the commercial scale-up of the 4" diameter Demo Plant contactors and matched phase separators, and associated piping, pumps, sensors, instruments, chemistry, and operational parameters up to the selected maximum 24" diameter contactor size design for the SMC;

confirm that the RapidSX™ technology performs as expected and performs equal to or better than conventional solvent extraction ("CSX") in all contactor sizes expected to be deployed at the Company's Louisiana SMC, under the most conservative chemistry assumptions;

The Results from the RSX-1 scale-up and optimization program were:

Ucore developed an optimized operating profile for intermediate-size contactors based on over 400 completed tests with 1-1/4", 2", 4", 12", and 24" contactor diameters and configurations of organic/aqueous ("O/A") ratios and hydraulic flux rates;

Ucore designed, compared, optimized, and validated a 24" diameter contactor assembly against a four (4) by 12" diameter contactor assembly (i.e., the same total area, working in parallel) to take advantage of RapidSX™'s inherent equipment flexibility and modularity for varying hydraulic flux rates. This was also done for other equivalent area contactor configurations.

Ucore selected the specific operational configurations and equipment for Enhanced Machine A and other planned SMC machines.

The Follow-On Enhanced Machine A activities from the RSX-1 scale-up and optimization program are:

all testing information now exists to incorporate the results into detailed design engineering

as part of the final Factory Acceptance Testing ("FAT") program, Ucore will test the now optimized Enhanced Machine A individual contactor assembly configuration (i.e., a two (2) x 8" diameter RapidSX™ contactor assembly) with the specifically selected components and operational parameters as part of RSX-2 & RSX-3, planned for the remainder of August and September of 2026

The extensive 12-month RSX-1 scale-up, optimization, and verification campaign was designed to evaluate mixing, phase continuity, hydraulic stability, pressure behavior, phase disengagement, and visible entrainment over a wide range of contactor diameters and operational profiles. Mass-transfer performance was compared with the CSX baseline, which represented the equilibrium reference and target performance level for determining whether the RapidSX™ contactors achieved the required extent of mass transfer - resulting in final contactor assembly equipment selections and optimized operating parameters for the Louisiana SMC.

"Ucore continues to make very deliberate progress in transitioning from its Kingston, Ontario, Commercialization and Demonstration Facility [CDF] to its first commercial-scale rare earth refinery in Louisiana," stated Mike Schrider, P.E., Ucore's Vice President and Chief Operating Officer. "As announced in May, the Company's first SMC RapidSX™ machine, Enhanced Machine A, will allow the processing of a variety of Western mixed rare earth carbonate and/or oxide sources into NdPr, samarium, gadolinium, and potentially yttrium, contributing to a critical Western need, as new US source restrictions take hold on January 1, 2027."

As Ucore reported on May 28, 2026, pending construction completion, commissioning, qualification, and receipt of all required funding and permits, Ucore's Louisiana SMC is designed to be capable of accepting mixed rare earth carbonate ("MREC") and mixed rare earth oxide ("MREO") from Western-friendly feedstock sources and processing up to ≈9,600 tpa of contained TREO. The SMC is designed to be constructed and rolled out in modules to take advantage of the inherent flexibility of the RapidSX™ technology platform and to produce NdPr, Pr, Nd, Sm, Gd, SmEuGd ("SEG"), Tb, Dy, and other rare earth oxide products and intermediates.

# # #

About Ucore Rare Metals Inc.

Ucore is focused on rare- and critical-metal resources, extraction, beneficiation, and separation technologies with the potential for production, growth, and scalability. Ucore's vision and plan are to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry.

Through strategic partnerships, Ucore aims to support the development of a more diversified and resilient North American REE supply chain through the near-term development of a heavy and light rare-earth processing facility in the US State of Louisiana, subsequent SMCs in Canada and Alaska, and the longer-term development of Ucore's 100% controlled Bokan-Dotson Ridge Rare Heavy REE Project on Prince of Wales Island in Southeast Alaska, USA ("Bokan").

Ucore is listed on the TSXV under the trading symbol "UCU" and in the United States on the OTC Markets' OTCQX® Best Market under the ticker symbol "UURAF."

For further information, please visit www.ucore.com.

Forward-Looking Statements

This press release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws. All statements in this release, other than statements of historical fact, that address future business development, technological development, engineering, procurement, construction, commissioning, commercial production, operating costs, capital costs, project timelines, throughput, product mix, feedstock processing, government funding, customer qualification, offtake, market prices, or other future events or developments are forward-looking statements.

Forward-looking statements in this release include, without limitation, statements regarding: the design, configuration and development of the Louisiana SMC; the expected number of RapidSX™ production lines and machines; expected throughput of 9,600 tonnes per annum of TREO; expected production of NdPr, Nd, Pr, Sm, Gd, Tb, and Dy; the expected sequencing and timing of Enhanced Machine A, Production Line 1, Production Line 2, and Production Line 3; estimated capital costs for Machine A and Production Line 1 and related infrastructure; expected operating characteristics, including potential reductions in unit operating costs and improvements in reliability; targeted milestones for engineering, construction, commissioning and commercial production; availability and sourcing of feedstock; customer engagement and potential product demand; rare earth market conditions and pricing; and the potential receipt of government funding and other financing.

Forward-looking statements are based on a number of material assumptions, including, without limitation: the successful completion and accuracy of baseline, front-end-engineering design and detailed engineering studies; the ability to complete further engineering, procurement, and construction activities as currently contemplated; the availability, cost, and timely delivery of equipment, materials, utilities, labour and construction services; the Company's ability to secure sufficient financing on acceptable terms; the receipt and timing of all required permits and approvals; the successful scale-up and commercial deployment of RapidSX™ technology from demonstration to commercial operation; the availability of qualified feedstock from third-party suppliers; successful customer qualification and offtake discussions; continued support from governmental partners; and general economic, market, and industry conditions, including assumptions regarding rare earth oxide prices, which are subject to significant volatility.

Forward-looking information relating to capital cost estimates and project design is based on a baseline engineering report and remains subject to refinement through further engineering and project development. Such estimates may not be directly comparable to previously disclosed estimates, which were prepared at an earlier stage of project development and may have included different scope elements, assumptions, or cost categories, including feedstock, working capital, or other non-capital items.

In addition, statements regarding expected operating efficiencies, cost reductions, reliability, and commercial performance are based on current engineering assumptions and preliminary analyses and are subject to validation through commissioning and commercial operations. There can be no assurance that such expectations will be achieved in whole or in part.

Although the Company believes that the assumptions underlying the forward-looking information are reasonable, there can be no assurance that such assumptions will prove to be accurate or that the anticipated results, performance, or achievements will be realized. Actual results may differ materially from those expressed or implied by the forward-looking information.

Factors that could cause actual results to differ materially include, without limitation: risks associated with the development, scale-up, and commercialization of new or unproven technologies; the risk that RapidSX™ may not perform at commercial scale as expected; engineering design changes; inaccuracies in capital or operating cost estimates; cost escalation due to inflation, supply chain disruption, or market conditions; delays or failures in procurement, construction, or commissioning; the inability to obtain or maintain required permits, approvals, or regulatory authorizations; challenges in securing adequate financing; adverse capital market conditions; variability in feedstock supply, quality, or pricing; failure to secure or maintain commercial relationships, customer qualification, or offtake arrangements; fluctuations and uncertainty in rare earth oxide prices and demand; the risk that indicative or quoted market prices, including for ex-China markets, may not be realized; operational risks once in production, including equipment failures or lower-than-expected recoveries; geopolitical risk; changes in applicable laws or regulations; environmental or permitting challenges; loss of key personnel; and general economic, business, or competitive conditions.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update forward-looking statements except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/308111

Source: Ucore Rare Metals Inc.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Represents an additional order for Ondas' Mistral Inc. under a previously awarded $982 million multi-year IDIQ supporting the U.S. Army's Lethal Unmanned Systems (LUS) program

Order strengthens Ondas' position in the U.S. Defense Market and demonstrates continued execution of Its defense growth strategy

Ondas is currently producing systems for delivery in the third quarter under the initial $190.8 million order for the LUS program

WEST PALM BEACH, FL / ACCESS Newswire / August 5, 2026 / Ondas Inc. (Nasdaq:ONDS) ("Ondas" or the "Company"), a leading provider of autonomous systems and next-generation defense and security technologies, announced today that its U.S.-based defense prime contractor, Mistral Inc., has received an over $50 million order from the U.S. Army for tactical Lethal Unmanned Systems (LUS). The order was issued under a previously awarded $982 million multi-year Indefinite Delivery, Indefinite Quantity ("IDIQ") contract supporting the U.S. Army's Lethal Unmanned Systems (LUS) program. Combined with the initial $190.8 million award under the LUS program, Mistral's total awards to date exceed $240 million.

The award represents an important expansion of Ondas' position in the precision-strike market. Together with Ondas' DZYNE and Rotron, Mistral strengthens Ondas' ability to develop, integrate, and deliver a broader portfolio of precision-strike solutions across multiple ranges, missions, and operational environments. Precision-strike is a rapidly growing segment of the global defense industry driven by increasing demand for accurate, responsive and deployable strike capabilities. The order also demonstrates the strategic rationale behind Ondas' acquisition of Mistral. Mistral provides Ondas with established access to major U.S. defense programs, long-standing customer relationships, prime-contractor capabilities and the infrastructure required to execute large, complex government programs.

"This order moves Ondas deeper into the precision-strike market, where demand from the U.S. Department of War and allied forces continues to accelerate," said Eric Brock, Chairman and CEO of Ondas. "Our focus now is on execution. Mistral is already producing systems for delivery beginning in the third quarter of 2026 under the initial LUS order, and this new award extends that production runway on the same Army contract vehicle. Our expanding operating footprint in the United States makes Ondas increasingly well positioned to compete for and execute large, multi-year programs like this one."

Mistral's established position within the U.S. defense ecosystem complements Ondas' growing portfolio of autonomous technologies, mission-planning capabilities, unmanned systems and advanced defense solutions. Ondas believes this combination creates opportunities to participate in a broader range of defense programs and to support customers across the full operational mission cycle, including intelligence and surveillance, target identification, mission planning, autonomous operations, precision strike and post-mission assessment. The award represents continued execution under the multi-year U.S. Army contract vehicle and provides Ondas with increased visibility into future production, integration, training and sustainment activity.

Ondas expects demand for tactical precision-strike and loitering-munition capabilities to continue expanding as the United States and allied defense forces prioritize distributed, autonomous and rapidly deployable systems. The order further demonstrates Ondas' strategy of combining differentiated technologies with established defense businesses that bring market access, customer relationships, manufacturing capacity and large-scale program-execution capabilities

About Ondas Inc.

Ondas Inc. (Nasdaq:ONDS) is a leading provider of autonomous systems, robotics, and mission-critical technologies for defense, homeland security, public safety, critical infrastructure, and industrial markets. The Company develops and deploys integrated unmanned and autonomous platforms across air, ground, and stratospheric environments, including autonomous drone systems, counter-UAS technologies, robotic ground systems, advanced unmanned aircraft and propulsion solutions, demining and engineering systems, and integrated sensing and communications technologies designed to support intelligence, surveillance, reconnaissance, security, and operational missions in complex environments. Ondas' solutions are deployed globally by government, defense, and commercial customers to protect infrastructure, borders, transportation networks, personnel, and strategic assets.

For additional information on Ondas Inc., visit www.ondas.com.

Forward-Looking Statements

Statements made in this release that are not statements of historical or current facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance, or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including the risks discussed under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, except as required by law.

Contacts

IR Contact for Ondas Inc.
888-657-2377
[email protected]

Media Contact for Ondas Inc.

Escalate PR
[email protected]

Preston Grimes
Marketing Manager, Ondas Inc.
[email protected]

SOURCE: Ondas Inc.

Zeta Global stock pared back some of its gains from earlier this week as investors booked profits following its earnings report. It retreated to $23 from this week’s high of $24.45. It remains about 65% above the lowest level this year, giving it a market capitalization of over $6 billion. 

In a statement on Tuesday, Zeta Global, a top company in the marketing space, announced that its revenue growth accelerated during the last quarter.

Its revenue jumped by 44% as more companies continued moving into its platform. It made $443 million during the quarter, up by $23 million from the midpoint of its previous guidance. In this, the number of super-scaled customers increased to 197, up by 17% YoY, with the average revenue per user (ARPU) moving to $1.8 million. 

This growth has been boosted by its collaborations with companies like OpenAI, Snowflake, and Plantir. As a result, the management believes that it has moved to an inflection point as these collaborations have brought together capabilities it has spent years building. In a statement, the CFO said:

“Our first-half performance and pipeline visibility gives us the confidence to significantly increase the midpoint of our revenue, adjusted EBITDA, free cash flow and GAAP EPS expectations.”

In this, it increased the guidance for the third quarter to between $469 and $472 million, up by $10 million from the previous guidance. This growth excludes the temporary benefit from its political business and its mergers amnd acquisition.

Additionally, the management expects that the annual revenue will grow to between $1.81 billion and $1.82 billion, with the annual EBITDA jumping to between $401 million and $406 million. The free cash flow is expected to jump to about $235 million. 

These numbers mean that the company’s growth is supercharging, which may help to justify its valuation, which is not all that big. The company has a forward price-to-earnings ratio of 24, and a rule-of-40 metric of 64%.

Most analysts tracking Zeta have a bullish rating for the company, with the consensus target being $28, up by 16.70% from the current level. In its recent rating, Freedom Capital maintained a strong buy rating, while Bank of America hiked the target from $24 to $28. DA Davidson hiked the target to $30.

Zeta Global stock chart | Source: TradingView

The daily chart shows that the Zeta Global share price jumped from a low of $10.68 in April 2025 to a high of $24.60 this week. It has jumped above the 50-day Exponential Moving Average (EMA).

There are signs that the stock has formed an ascending triangle pattern, a common bullish continuation sign in technical analysis. It has soared above the Ichimoku cloud and the Supertrend indicators. 

Therefore, the most likely scenario is where the stock resumes the uptrend, potentially to the year-to-date high of $26. A move above that level will point to more gains in the long term, potentially to $27.85, its highest level in December 2024. 

watch now

Uber issued a forecast for bookings and earnings that trailed analysts' estimates, while second-quarter profit was in line with expectations. Shares sank about 3.5% on Wednesday following the print.

Here's how the company did versus analysts' estimates compiled by LSEG:

Earnings per share: 81 cents vs. 81 cents expectedRevenue: $14.19 billion vs. $14.24 billion expectedRevenue increased 12% from $12.65 billion a year earlier. Net income climbed to $2.39 billion, or $1.17 a share, from $1.35 billion, or 63 cents a share, a year ago.

Uber's core mobility service accounted for $7.36 billion of second-quarter sales, while delivery revenue reached $5.25 billion. Mobility gross bookings rose 22% from a year to $28.99 billion, and delivery bookings jumped 26% $27.46 billion. Total bookings of $58 billion topped the $57.23 billion average analyst estimate, according to StreetAccount.

For the third quarter, Uber sees bookings of $59.25 billion at the middle of its range. That trails the average StreetAccount estimate of $59.33 billion. And the company's EPS forecast of 84 cents to 88 cents fell below the 89-cent average analyst estimate, according to LSEG.

Uber shares are down 12% this year as of Tuesday's close, while the Nasdaq is up 14% over that stretch.

Uber stock chart

Uber is pushing further into deliveries, and last month announced a $14.8 billion agreement to acquire Germany's Delivery Hero. That deal will increase the number of markets where Uber can deliver food and groceries.

CEO Dara Khosrowshahi said in prepared remarks ahead of the earnings call that the World Cup was a boon for the ride-hail business in the quarter. More than 8 million tourists took rides across host cities in the U.S., Canada and Mexico

Uber is also continuing to make big bets on autonomous vehicles.

Read more CNBC tech newsSpaceX revenue jumps 92% and AI costs soar in first earnings report since IPONJ files antitrust suit against Amazon, alleging it unlawfully wielded power over delivery contractorsPalantir stock skyrockets on 'otherworldly' commercial revenue — here's what's driving the demandHow the 'Baby iPhone' and an Apple supplier leak explain China's recent supply chain movesThe company said it expects to commit more than $10 billion in coming years to "bring AVs to market at scale." Uber, which has been inking partnerships with robotaxi providers, doesn't break out the share of rides or deliveries that have drivers and those that don't.

"As the industry shifts from proving the technology to commercializing it at scale," Uber is building "one of the most valuable positions in the AV ecosystem," Khosrowshahi said.

However, early robotaxi partner Waymo appears to be pulling away. The companies recently said they would be ending an exclusive agreement in Atlanta and Austin, Texas, by early 2028.

Uber also announced on Wednesday that it has cleared another hurdle in offering autonomous rides in London with UK robotaxi company Wayve.

Transport for London has granted Private Hire Vehicle licences to Wayve robotaxis, confirming that the vehicles meet safety standards. Uber said more than 100,000 people have signed up to be the first riders.

"This licence is a key milestone in bringing autonomous rides to London on Uber," said Global Head of Autonomous Mobility Operations Annie Duvnjak in a statement announcing the news.

Amazon’s AI spending is settling a debate between the bulls and the bears. Amazon Web Services (AWS) CEO Matt Garman spent Monday on Bloomberg Technology arguing that AWS’s growth is only getting started. He then went to X and quantified it in a way that undercuts every bear case that AI demand is topping out. “Much of our capacity is already spoken for through 2027 and into 2028, and demand still significantly outstrips supply,” Garman wrote. “We’re going to keep building to keep up with what customers are asking for.”

That single promise reframes the debate over hyperscaler capex. Garman is telling the market that AWS has already booked its next two years of infrastructure, which is why the company is comfortable spending at a historic pace.

The Numbers Behind the Quote Amazon.com (NASDAQ:AMZN | AMZN Price Prediction) reported Q2 2026 AWS revenue of $42.232 billion, up 37% year-over-year, which management flagged as the fastest growth in 18 quarters. AWS Q2 operating margin came in at 39.4%, and capital expenditures reached $54.208 billion in the quarter, a 68.44% year-over-year jump.

CEO Andy Jassy sized the AI stack directly, stating: “AWS is booming, growing 36.7% year-over-year in Q2, our fastest growth in 18 quarters, and our AI and Chips businesses each eclipsed run rates of more than $25 billion.” Both are growing at triple-digit rates. AWS chief Garman also flagged a large shift from training to inference workloads, the actual usage of models, which tends to produce sticky, recurring compute demand rather than one-off training bursts.

UBS estimates AWS growth will accelerate to 48% next year as Trainium scales with some help from OpenAI. Prediction markets are echoing the bullish buildout thesis: Polymarket traders assign a 96.3% probability that Amazon’s 2026 capex clears $190 billion. Shares have rallied 20.1% in the past five trading sessions.

The Suppliers Locked Into the Buildout If AWS capacity through 2028 is committed, the merchant silicon and interconnect vendors feeding those data centers have equally visible order books.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Amazon didn't make the cut. Grab the names FREE today.

Marvell Technology (NASDAQ:MRVL) posted Q1 FY2027 revenue of $2.418 billion, up 28% year over year, with data center contributing $1.833 billion, or 76% of the total pie. CEO Matt Murphy told investors, “We are seeing exceptional AI-related bookings, and as a result, we are significantly raising Marvell’s revenue outlook for both fiscal 2027 and fiscal 2028.” Marvell shares climbed 14.33% on August 4 as the AWS quote circulated.

Astera Labs (NASDAQ:ALAB), which sells connectivity silicon for scale-up AI racks, reported Q1 revenue of $308.4 million, up 93.4% year-over-year, and guided Q2 to a range of $355 million to $365 million. The stock is up 92.99% year-to-date.

Credo Technology (NASDAQ:CRDO) closed fiscal 2026 with full-year revenue of $1.34 billion, up 205.7%, and guided Q1 FY27 to a range of $465 million to $475 million. CEO Bill Brennan credited a vertically integrated approach that he said enables customers to accelerate cluster time-to-stability, maximize GPU utilization, and reduce data center power costs.

What to watch: whether Q3 AWS bookings and hyperscaler capex commentary from Marvell, Astera, and Credo confirm Garman’s 2028 visibility. If they do, Amazon’s AI spending starts to look less like a leap of faith and more like a supply chain already being claimed years in advance.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Amazon didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

NASDAQ | TSX: ACB

Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue Safari Flower Company Receives Three-Year EU-GMP Certification, Strengthens Ability to Supply Growing, High-Margin International Medical Cannabis Markets Maintains Strong Balance Sheet with $149.1 million of Cash, Cash Equivalents2and Short-Term Investments with no Debt , /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2027 ending June 30, 2026.

FY27 Q1 Earnings "We remain confident in our commercial execution, supported by our genetics program and regulatory and operational expertise which underpin our leadership in Canada, Germany, Poland, Australia, and New Zealand. These competitive advantages support our strategy to invest further in EU-GMP manufacturing capacity so that we can supply growing international markets for medical cannabis and thereby maintain and expand our market share," said Executive Chairman and Chief Executive Officer for Aurora, Miguel Martin.

"The first quarter reflects our continued strength, as we delivered international revenue growth and leading adjusted gross margins1, anchored by a cost structure designed to support topline growth. In the second quarter, we expect both revenue and Adjusted EBITDA1 to improve sequentially, driven by increasing global patient demand for medical cannabis," concluded Mr. Martin.

[1] This news release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. See "Non-GAAP Measures" below for reconciliations of non-GAAP financial measures to GAAP financial measures.

[2] Cash and Cash Equivalents refers to cash, restricted cash and cash equivalents.

First Quarter 2027 Highlights

(Unless otherwise stated, comparisons are made between fiscal Q1 2027 and Q1 2026 results and are in Canadian dollars)

On February 17, 2026, the Company completed the divestiture of its 50.1% ownership interest in Bevo Agtech Inc. ("Bevo"). As such, Bevo has been excluded from the Company's comparative figures, due to its classification as a discontinued operation.

Consolidated Revenue and Adjusted Gross Profit:
Total net revenue was $67.6 million, as compared to $74.1 million in the prior year period. The 9% decrease was mainly due to lower quarterly net revenue in Canadian medical cannabis and the wind down in consumer cannabis, offset by higher net revenue in international medical cannabis and wholesale bulk cannabis.

Consolidated adjusted gross margin before fair value adjustments1 was 58% and 64% in the prior year period. Adjusted gross profit before FV adjustments1 was $39.5 million compared to $47.7 million in the prior year period.

Medical Cannabis:
Medical cannabis net revenue was $64.0 million, as compared to $64.8 million in the prior year period, a 1% decrease.

Canadian medical cannabis net revenue1 was $20.7 million, as compared to $27.7 million in the prior year period. The 25% decrease was mainly due to changes in the federal reimbursement program effective April 1, 2026, which lowered reimbursement rates by approximately 30%.

International medical cannabis net revenue increased to $43.3 million from $37.1 million in the prior year period. The 17% increase was mainly due to higher sales in Germany driven by increased patient demand.

Adjusted gross margin before fair value adjustments1 on medical cannabis net revenue1 was 61% as compared to 69% in the prior year period. The year-over-year decrease was mainly due to changes to the federal reimbursement program effective April 1, 2026, which decreased reimbursement rates by approximately 30%.

Consumer Cannabis:
Aurora's consumer cannabis net revenue was $2.1 million, compared to $7.9 million in the prior year period. The decrease was due to our strategic shift to focus on Canadian and international medical cannabis and wind down our consumer cannabis business.

Adjusted gross margin before fair value adjustments1 on consumer cannabis net revenue1 was 20%, compared to 33% in the prior year period. The decrease was mainly due to the company selling products at reduced prices to reduce inventory impairments related to the wind down of the consumer channel.

Adjusted Selling, General and Administrative ("Adjusted SG&A"):
Adjusted SG&A1 was $35.1 million, compared to $36.1 million in the prior year period.

Net Income (Loss):

Net loss from continuing operations was $4.0 million, compared to $10.2 million for the prior year period. The decrease in net loss from continuing operations of $6.2 million was a combination of an increase in gross profit of $2.1 million, a decrease in operating expenses of $1.1 million and an increase in other income of $3.4 million. The increase in gross profit includes an increase in gain on changes in fair value of biological assets of $12.6 million, partially offset by a decrease in net revenue of $6.5 million.

Adjusted Net Income:
Adjusted net income1 was $3.8 million compared to $6.6 million for the prior year period. The decrease of $2.8 million was mainly due to a decrease in adjusted gross profit before fair value adjustments of $8.3 million, partially offset by a decrease in adjusted SG&A of $1.0 million and an increase in other income of $3.4 million.

Adjusted EBITDA: 
Adjusted EBITDA1 was $3.4 million compared to $10.8 million for the prior year period. The decrease of $7.4 million was mainly due to a decrease of $8.3 million in adjusted gross profit before fair value adjustments partially offset by a decrease in adjusted SG&A of $1.0 million.

Free Cash Flow:
Free cash flow was an outflow $5.8 million compared to an inflow $6.8 million in the prior year period. The decrease in free cash flow of $12.6 million was primarily due to a decrease in gross profit before fair value adjustments of $9.7 million.

Safari Flower Company Acquisition:
The accretive acquisition of Safari Flower Company ("Safari"), which closed on April 14, 2026, provides us with a 59,000 square foot EU-GMP certified indoor cultivation and manufacturing facility, adding critical EU GMP capacity to support further revenue growth in the expanding, high margin international markets.

This incremental capacity is expected to improve product availability and speed to market, while also reducing reliance on third-party suppliers, which should help drive top line growth. We intend to invest approximately $3.5 million over the next three years in growth capital improvements to drive operational efficiencies and maximize cultivation output to deliver reduced manufacturing costs and higher margins.

On July 23, 2026, we announced that Safari received its EU-GMP certification for its Ontario facility, which is granted for a three-year term. For further information relating to this transaction please refer to the 'Investing Activities' section of the FY27 Q1 MD&A.

Fiscal Full Year 2027 Outlook (Unchanged):
Our reiterated outlook now capitalizes on the strategic decisions taken to exit our low margin Canadian Consumer and Plant Propagation businesses, which will allow the Company to reallocate resources to focus exclusively on global medical cannabis. We believe this is our highest return and growth opportunity to create shareholder value.

Over the next few quarters, we are purposely investing in our international business through strategic sales initiatives and EU-GMP capacity expansion to support growth in our most profitable markets. This includes our new wholly owned subsidiary, Safari Flower Company, a trusted cultivator and manufacturer of high-quality medical cannabis, which provides incremental capacity to support further revenue growth in our key high margin international markets.

These investments support our goal of driving the business to new records for revenue and adjusted EBITDA and generate sustained returns for our shareholders in the long term.

In the fiscal second quarter, we expect revenue and adjusted EBITDA to be sequentially higher than in the fiscal first quarter.

Key Quarterly Financial Results

($ thousands)

Three months ended

June 30, 2026

June 30, 2025

Financial Results

Net revenue (1)

67,554

74,076

Medical cannabis net revenue(2)

64,036

64,768

Gross profit

35,622

33,528

Gross profit before fair value ("FV") adjustments (1)

29,192

38,849

Gross margin (3)

53 %

45 %

Gross margin before FV adjustments (3)

43 %

52 %

Adjusted gross margin before FV adjustments on total net revenue (4)

58 %

64 %

Adjusted gross margin before FV adjustments on medical cannabis net revenue (4)

61 %

69 %

Operating expenses

44,353

45,470

General and administration

24,602

26,872

Sales and marketing

15,591

14,455

Adjusted selling, general & administration expense ("adjusted SG&A")(4)

35,084

36,095

Other income (expenses)

5,101

1,685

Net loss from continuing operations

(4,033)

(10,186)

Net income (loss) from discontinued operations, net of taxes

—

(9,679)

Net loss

(4,033)

(19,865)

Adjusted earnings before interest, taxes, depreciation and amortization ("adjusted EBITDA") (4)

3,443

10,815

Adjusted net income (4)

3,811

6,598

Net cash provided by (used in) operating activities from continuing operations

(4,446)

7,679

Free cash flow (4)

(5,793)

6,772

(1)

As presented in the interim condensed consolidated statements of loss and comprehensive loss.

(2)

See "Net Revenue" section in the MDA.

(3)

Gross margin and Gross margin before FV adjustments, respectively, are calculated as gross profit and gross profit before FV adjustments, respectively, divided by net revenue.

(4)

These terms are defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A, including information on reconciliation to the most directly comparable IFRS measure. See "Non-GAAP Measures" below for reconciliations of non-GAAP financial measures to GAAP financial measures.

Conference Call

Aurora will host a conference call today, Wednesday, August 5, 2026, to discuss these results. Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer, will host the call starting at 8:00 a.m. Eastern time | 6:00 a.m. Mountain Time. A question and answer session will follow management's presentation.

DATE:

Wednesday, August 5, 2026

TIME:

8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time

WEBCAST:

Click Here

About Aurora Cannabis

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™. 

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's fiscal 2027 first quarter results; competitive advantages, including but not limited to commercial execution, genetics, and regulatory and operational expertise; the Company's leadership in Canada, Germany, Poland, Australia, and New Zealand; the Company's ability to invest further in EU GMP manufacturing capacity; the Company's ability to continue to supply growing international medial cannabis markets; growth opportunities; expectations for improvements in revenue, Adjusted EBITDA, and increased global patient demand for medical cannabis; the acquisition of Safari Flower Company and related benefits for the Company, including increased supply to international markets and reduced reliance on third party purchases; the Company's planned investment in growth capital improvements to improve operational efficiencies and to maximize cultivation output; statements made under the heading "Fiscal Full Year 2027 Outlook (Unchanged)", including but not limited to, statements regarding the reallocation of resources to focus on global medical cannabis, the Company's planned investment in the international business through strategic sales initiatives and EU-GMP capacity expansion to support growth in its most profitable markets, and expectations for those efforts to help offset the impact of margin reductions in the Canadian medical business; and expectations for revenue and Adjusted EBITDA in the fiscal 2027 second quarter.

These forward-looking statements are only predictions. Forward-looking information or statements contained in this news release have been developed based on the Company and its management's good faith assumptions relating to the financial, market, regulatory and other relevant environments that will exist and affect the Company's business and operations in the future. Forward-looking information and statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management at the date the statements are made including, among other things, assumptions about: development costs remaining consistent with budgets; the ability to manage anticipated and unanticipated costs; access to favorable equity and debt capital markets; the ability to raise sufficient capital to advance the business of the Company; favorable operating and economic conditions; political and regulatory stability; obtaining and maintaining all required licenses and permits; receipt of governmental approvals and permits; sustained labour stability; stability in financial and capital goods markets; favorable production levels and costs from the Company's operations; the pricing of various cannabis products; the level of demand for cannabis products; the availability of third-party service providers and other inputs for the Company's operations; and the Company's ability to conduct operations in a safe, efficient, and effective manner. The Company does not give any assurance that the assumptions on which forward-looking information or statements are based will prove to be correct, or that the Company's business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company's control. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete construction projects and facilities improvements, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion to revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crisis ,and other risks as set out under the heading "Risk Factors" in the Company's annual information form dated June 11, 2026 and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Non-GAAP Measures

This news release contains reference to certain financial performance measures that are not recognized or defined under IFRS (termed "Non-GAAP Measures"). As a result, this data may not be comparable to data presented by other licensed producers of cannabis and cannabis companies. Non-GAAP Measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company's operating results, underlying performance and prospects in a manner similar to Aurora's management. Accordingly, these non-GAAP Measures are intended to provide additional information and to assist management and investors in assessing financial performance and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. The information included under the heading "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" in the FY27 Q1 MD&A is incorporated by reference into this news release. The MD&A is available on the Company's issuer profiles on SEDAR+ at www.sedarplus.com and on the U.S. Securities and Exchange Commission's (the "SEC") EDGAR website at www.sec.gov.

Net Revenue, Adjusted Gross Profit and Margin

Net revenue, adjusted gross profit before FV adjustments, and adjusted gross margin before FV adjustments are Non-GAAP Measures and can be reconciled with revenue, gross profit and gross margin, the most directly comparable GAAP financial measures, respectively, as follows:

($ thousands)

Three months ended

June 30, 2026

June 30, 2025

Medical cannabis net revenue:

     Canadian medical cannabis net revenue

20,699

27,674

     International medical cannabis net revenue

43,337

37,094

Total medical cannabis net revenue

64,036

64,768

     Consumer cannabis net revenue

2,060

7,875

     Wholesale bulk cannabis net revenue

1,458

1,433

Total net revenue(1)

67,554

74,076

(1)

As presented in the interim condensed consolidated statements of loss and comprehensive loss.

Adjusted EBITDA

The following is the Company's adjusted EBITDA:

($ thousands)

Three months ended

June 30, 2026

June 30, 2025 (3)

Net loss from continuing operations

(4,033)

(10,186)

Income tax expense (recovery)

403

(71)

Other income

(5,101)

(1,685)

Share-based compensation

693

2,186

Depreciation and amortization

3,427

3,560

Business development costs

1,589

361

Inventory and biological assets fair value and impairment adjustments

1,356

11,418

Business transformation costs (1)

5,109

5,232

Adjusted EBITDA (2)

3,443

10,815

(1)

Business transformation related charges include costs related to restructuring, certain IT project costs, sublease income, severance and retention costs in connection with the consumer channel exit, and legal provisions.

(2)

Adjusted EBITDA is defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A, including information on reconciliation to the most directly comparable IFRS measure.

(3)

Prior period comparatives were adjusted to include the adjustments for markets under development, business transformation costs and non-recurring charges related to non-core bulk cannabis wholesale to be comparable to the current period presentation.

Adjusted Net Income

The following is the Company's adjusted net income (loss):

($ thousands)

Three months ended

June 30, 2026

June 30, 2025

Net income (loss) from continuing operations

(4,033)

(10,186)

Inventory and biological assets fair value and impairment adjustments

1,356

11,418

Business development costs

1,589

361

Business transformation costs (1)

4,899

5,005

Adjusted net income (2)

3,811

6,598

(1)

Business transformation related charges include costs related to restructuring costs, certain IT project costs, severance and retention costs in connection with the consumer channel exit, and legal provisions.

(2)

Adjusted net income is defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A, including information on reconciliation to the most directly comparable IFRS measure.

Adjusted SG&A

Adjusted SG&A is a Non-GAAP Measure and can be reconciled with sales and marketing and general and administrative expenses, the most directly comparable GAAP financial measure, as follows:

Three months ended

($ thousands)

June 30, 2026

June 30, 2025

General and administration

24,602

26,872

Sales and marketing

15,591

14,455

Business transformation costs (2)

(5,109)

(5,232)

Adjusted SG&A (1)

35,084

36,095

(1)

Adjusted SG&A is defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A, including information on reconciliation to the most directly comparable IFRS measure..

(2)

Business transformation related charges include costs related to restructuring, certain IT project costs, sublease income, severance and retention costs in connection with the consumer channel exit, and legal provisions.

Free Cash Flow

The table below outlines free cash flow for the periods ended:

Three months ended

($ thousands)

June 30, 2026

June 30, 2025

Net cash provided by (used in) operating activities from continuing operations

(4,446)

7,679

Less: maintenance capital expenditures(1)

(1,347)

(907)

Free cash flow(2)

(5,793)

6,772

(1)

Maintenance capital expenditures includes the costs to sustain facilities, machinery and equipment in working order to support operations and excludes discretionary investments for revenue growth.

(2)

Free cash flow is defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A, including information on reconciliation to the most directly comparable IFRS measure.

Working Capital

Working capital is a Non-GAAP Measure and can be reconciled with total current assets and total current liabilities, the most directly comparable GAAP financial measure, as follows:

($ thousands)

Three months ended

June 30, 2026

June 30, 2025

Total current assets

393,449

465,301

Total current liabilities

(73,429)

(156,885)

Working capital

320,020

308,416

SOURCE Aurora Cannabis Inc.